ArticleEClinicalMedicine2025
Metacognitive therapy and work-focus for patients with depression, anxiety or comorbid depression and anxiety on sick leave: a single-centre, open-label randomised controlled trial.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03301922 (Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders: A Randomized Waiting List Controlled Trial
Who cites it
3 citing papers in PubMed.
- Beliefs About Working with Health Problems and Support at Work as Predictors of Sick Leave at Post-treatment and at Follow-Up: Secondary Analyses of a Randomised Controlled Trial with Registry Data.Journal of occupational rehabilitation · 2026Article
- Group metacognitive therapy for students with anxiety: an uncontrolled pre-post study of feasibility and associated outcomes.Frontiers in psychiatry · 2026Article
- Generic group metacognitive therapy for depression in specialized mental health care: an open trial with 6- and 12-month follow-ups.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Employment is a key determinant of health, but mental health treatments have limited success on return-to-work (RTW) in depression and anxiety. We investigated the effectiveness of metacognitive therapy combined with work-focused components (MCT + WF) to improve RTW and reduce anxiety and depression in patients on sick leave. Methods: This single-centre, open-label, randomised controlled trial was conducted at an outpatient clinic (Diakonhjemmet Hospital) in Norway. Eligible patients were adults on sick leave with depression and/or anxiety. Patients with severe mental disorder or substance abuse were excluded. Participants were randomly assigned using computer-generated block randomisation, stratified by gender and percentage of sick leave, to receive either immediate MCT + WF or delayed MCT + WF after 8-12 weeks on a waitlist. Outcome assessors were blinded. Primary outcomes were depression (BDI-II), anxiety (BAI), and RTW at 12 weeks. Sick leave data were obtained from a national registry and self-report; symptoms were self-reported. Analyses followed the intention-to-treat principle, including all randomised participants. This trial was registered with ClinicalTrials.gov, NCT03301922. Findings: Between Sept 11, 2017, and Nov 17, 2020, 236 patients were enrolled and randomly assigned to immediate MCT + WF ( Interpretation: Immediate MCT + WF significantly improved RTW and reduced symptoms of depression and anxiety compared with waiting. Generalisability may be constrained by Norway's welfare system; strengths include registry data and naturalistic outpatient setting. The favourable outcomes suggest that MCT + WF could be integrated into mental health care. Funding: The study was funded by the South-Eastern Norway Regional Health Authority and DAM foundation-Mental Health, Diakonhjemmet Hospital.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.